Pacer Advisors Inc. Has $5.24 Million Stake in GE HealthCare Technologies Inc. $GEHC

Pacer Advisors Inc. decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 69,744 shares of the company’s stock after selling 14,038 shares during the quarter. Pacer Advisors Inc.’s holdings in GE HealthCare Technologies were worth $5,238,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. grew its position in GE HealthCare Technologies by 4.2% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 159,882 shares of the company’s stock worth $11,842,000 after buying an additional 6,479 shares in the last quarter. Wedge Capital Management L L P NC acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at approximately $26,859,000. Lineweaver Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth approximately $592,000. Osaic Holdings Inc. grew its holdings in shares of GE HealthCare Technologies by 18.1% during the 2nd quarter. Osaic Holdings Inc. now owns 224,869 shares of the company’s stock worth $16,674,000 after purchasing an additional 34,499 shares in the last quarter. Finally, National Bank of Canada FI increased its position in shares of GE HealthCare Technologies by 133.3% during the second quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock valued at $66,640,000 after purchasing an additional 514,007 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on GEHC. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. BTIG Research reissued a “buy” rating and issued a $87.00 target price on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Morgan Stanley increased their price target on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 30th. Finally, Citigroup raised their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $87.09.

GE HealthCare Technologies Trading Down 0.6%

Shares of GE HealthCare Technologies stock opened at $83.15 on Tuesday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The stock has a market capitalization of $37.88 billion, a P/E ratio of 17.18, a price-to-earnings-growth ratio of 3.49 and a beta of 1.09. The company has a 50-day simple moving average of $78.89 and a 200 day simple moving average of $75.91. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.